Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.355NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.355NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.355NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GA.7.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GA.7.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.7.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.403NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.403NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.403NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.27NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.27NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.30NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.30NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.30NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GW.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GW.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GW.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.40NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.40NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.40NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FY.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.2.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.2.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.367NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.367NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.367NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.1.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.1.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.3.13NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.3.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.3.13NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.385NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.385NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.385NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.45NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.45NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.45NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.244NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.244NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.244NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JD.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JD.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used